$20.02
-0.67-3.24%
Last update: Nov 6, 7:28 AM

The average analyst price target for Replimune Group is $15, 25.3% below the current price. Of 9 analysts, 6 rate it Buy, 2 Hold and 1 Sell. Targets range from $2 to $31. The latest change came on Oct 29, 2026, when Leerink Partners raised its price target on Replimune Group from $19 to $31 and kept an Outperform rating.
Price Target Range — 12 Quarters
Analyst Consensus — 9 Analysts
Rating Trend — Last 9 Months